About Unzyme Laboratories

Pioneering Human Enhancement Since 2008

We believe in a future where human limitations are a choice, not a constraint. For over 15 years, we've worked to make that future a reality.

Our Mission

To liberate humanity from the constraints of biological evolution by developing safe, effective enhancement technologies that empower individuals to reach their full potential.

"Let's make you the cyborg you deserve to be."

Our Vision

A world where every person has access to enhancements that improve their health, capabilities, and quality of life. Where "human limitation" is a historical term.

"It's time to say NO to anthropomorphic limitations."

Our Values

01

Scientific Excellence

Every product we release is backed by rigorous research and clinical testing. We never compromise on the quality of our science.

02

Human Empowerment

Our technologies exist to serve humanity, giving individuals control over their own enhancement journey and biological destiny.

03

Accessible Innovation

We work to make our enhancements available to everyone who seeks them, removing barriers to human optimization.

04

Ethical Progress

We advance human capability while maintaining the highest standards of participant safety and informed consent.

Our Journey

2008

Unzyme Laboratories founded in Helsinki, Finland

2009

UPG Alpha operational - first proving ground established

2010

First successful neural interface prototype developed

2011

UPG Alpha decommissioned; UPG Beta opens

2012

UPG Beta closed; UPG Gamma (remote Finland) opens

2013

UPG Delta (Jyväskylä) established

2018

Project STAVANGER initiated - neural enhancement research begins

2020

CardioBoost Pro achieves FDA approval

2022

OptiLens Pro launches commercially

2024

UPG Epsilon (Helsinki) opens

2025

UPG Zeta (Wrocław) groundbreaking - walk-in trials announced

15+ Years of Research
10,000+ Trial Participants
6 Global Facilities
500+ Researchers & Staff

Ready to Begin Your Enhancement Journey?

Whether you're interested in our products, want to participate in research, or are considering a career with us, we'd love to hear from you.